BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23630972)

  • 1. [Idiopathic pulmonary fibrosis: treatment with pirfenidone].
    Cano-Jiménez E
    Arch Bronconeumol; 2012 Oct; 48 Suppl 2():16-8. PubMed ID: 23630972
    [No Abstract]   [Full Text] [Related]  

  • 2. Idiopathic pulmonary fibrosis and pirfenidone.
    Collard HR
    Eur Respir J; 2010 Apr; 35(4):728-9. PubMed ID: 20356985
    [No Abstract]   [Full Text] [Related]  

  • 3. POINT: Should All Patients With Idiopathic Pulmonary Fibrosis, Even Those With More Than Moderate Impairment, Be Treated With Nintedanib or Pirfenidone? Yes.
    King CS; Nathan SD
    Chest; 2016 Aug; 150(2):273-5. PubMed ID: 27292047
    [No Abstract]   [Full Text] [Related]  

  • 4. [Patient treated with pirfenidone].
    Valenzuela C
    Arch Bronconeumol; 2012 Oct; 48 Suppl 2():19-20. PubMed ID: 23630973
    [No Abstract]   [Full Text] [Related]  

  • 5. COUNTERPOINT: Should All Patients With Idiopathic Pulmonary Fibrosis, Even Those With More Than Moderate Impairment, Be Treated With Nintedanib or Pirfenidone? No.
    Brown KK
    Chest; 2016 Aug; 150(2):276-8. PubMed ID: 27292046
    [No Abstract]   [Full Text] [Related]  

  • 6. Severe Colitis Associated with Pirfenidone Use in Idiopathic Pulmonary Fibrosis.
    Fiddler CA; Simler N; Parfrey H; Miremadi A; Chilvers ER
    Ann Am Thorac Soc; 2016 Aug; 13(8):1430-2. PubMed ID: 27509160
    [No Abstract]   [Full Text] [Related]  

  • 7. Pirfenidone treatment in idiopathic pulmonary fibrosis: too much of a great expectation?
    Papiris SA; Kagouridis K; Kolilekas L; Triantafillidou C; Tsangaris I; Manali ED
    Eur Respir J; 2012 Sep; 40(3):794-5. PubMed ID: 22941551
    [No Abstract]   [Full Text] [Related]  

  • 8. Pirfenidone Initiates a New Era in the Treatment of Idiopathic Pulmonary Fibrosis.
    Selvaggio AS; Noble PW
    Annu Rev Med; 2016; 67():487-95. PubMed ID: 26565677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nintedanib and pirfenidone. New antifibrotic treatments indicated for idiopathic pulmonary fibrosis offer hopes and raises questions.
    Raghu G; Selman M
    Am J Respir Crit Care Med; 2015 Feb; 191(3):252-4. PubMed ID: 25635489
    [No Abstract]   [Full Text] [Related]  

  • 10. Pirfenidone for the treatment of idiopathic pulmonary fibrosis.
    Poletti V; Ravaglia C; Tomassetti S
    Expert Rev Respir Med; 2014 Oct; 8(5):539-45. PubMed ID: 25113033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pirfenidone treatment of idiopathic pulmonary fibrosis.
    Azuma A
    Ther Adv Respir Dis; 2012 Apr; 6(2):107-14. PubMed ID: 22333982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacological properties and clinical effects of the antifibrotic agent pirfenidone (Pirespa) for treatment of idiopathic pulmonary fibrosis].
    Tokura T; Oku H; Tsukamoto Y
    Nihon Yakurigaku Zasshi; 2009 Aug; 134(2):97-104. PubMed ID: 19672005
    [No Abstract]   [Full Text] [Related]  

  • 13. Is pirfenidone effective for idiopathic pulmonary fibrosis?
    Jeldres A; Labarca G
    Medwave; 2017 Jan; 17(Suppl1):e6843. PubMed ID: 28112713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pirfenidone: Clinical trials and clinical practice in patients with idiopathic pulmonary fibrosis.
    Bando M
    Respir Investig; 2016 Sep; 54(5):298-304. PubMed ID: 27566376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraindividual response to treatment with pirfenidone in idiopathic pulmonary fibrosis.
    Loeh B; Drakopanagiotakis F; Bandelli GP; von der Beck D; Tello S; Cordani E; Rizza E; Barrocu L; Markart P; Seeger W; Guenther A; Albera C
    Am J Respir Crit Care Med; 2015 Jan; 191(1):110-3. PubMed ID: 25551350
    [No Abstract]   [Full Text] [Related]  

  • 16. Pirfenidone for idiopathic pulmonary fibrosis.
    Bouros D
    Lancet; 2011 May; 377(9779):1727-9. PubMed ID: 21571363
    [No Abstract]   [Full Text] [Related]  

  • 17. Predictors of the clinical effects of pirfenidone on idiopathic pulmonary fibrosis.
    Arai T; Inoue Y; Sasaki Y; Tachibana K; Nakao K; Sugimoto C; Okuma T; Akira M; Kitaichi M; Hayashi S
    Respir Investig; 2014 Mar; 52(2):136-43. PubMed ID: 24636270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials.
    Noble PW; Albera C; Bradford WZ; Costabel U; Glassberg MK; Kardatzke D; King TE; Lancaster L; Sahn SA; Szwarcberg J; Valeyre D; du Bois RM;
    Lancet; 2011 May; 377(9779):1760-9. PubMed ID: 21571362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary fibrolysis in a patient with idiopathic pulmonary fibrosis: improvement of clinical and radiological pattern after treatment with pirfenidone.
    Varone F; Mastrobattista A; Franchi P; Viglietta L; Poletti V; Tomassetti S; Dubini A; Tagliaboschi L; Calandriello L; Farchione A; Larici AR
    Clin Respir J; 2018 Jan; 12(1):347-351. PubMed ID: 27322356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pirfenidone on breathlessness in patients with idiopathic pulmonary fibrosis.
    Glassberg MK; Wijsenbeek MS; Gilberg F; Petzinger U; Kirchgaessler KU; Albera C
    Eur Respir J; 2019 Sep; 54(3):. PubMed ID: 31164431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.